Logo image of MIRA

MIRA PHARMACEUTICALS INC (MIRA) Stock Earnings & Estimates

USA - Nasdaq - NASDAQ:MIRA - US60458C1045 - Common Stock

1.45 USD
+0.05 (+3.57%)
Last: 12/2/2025, 3:40:45 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2020 2021 2022 2023 2024 2025 2026
Revenue
YoY % growth
MIRA revenue by date.MIRA revenue by date.
N/AN/A
EBITDA
YoY % growth
MIRA ebitda by date.MIRA ebitda by date.
N/AN/AN/AN/AN/AN/A
-9.81%
N/A
6,240.78%
EBIT
YoY % growth
MIRA ebit by date.MIRA ebit by date.
-67.6K-2.152M
-3,083.73%
-7.048M
-227.47%
-8.526M
-20.97%
-8.018M
5.96%
N/A
-12.57%
N/A
6,225.87%
Operating Margin
MIRA operating margin by date.MIRA operating margin by date.
N/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
MIRA eps by date.MIRA eps by date.
N/AN/AN/AN/A-0.52
25.03%
N/A
27.42%
N/A
74.32%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25
EPS
Q2Q % growth
-0.04
72.80%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
N/A
EBIT
Q2Q % growth
N/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-0.06
57.14%
-0.080.0226.47%
Q2 2025
Q2Q % growth
-0.09
18.18%
-0.130.0432.13%
Q1 2025
Q2Q % growth
-0.11
8.33%
-0.150.0425.63%
Q4 2024
Q2Q % growth
-0.15
36.06%
-0.240.0937.42%
Q3 2024
Q2Q % growth
-0.14
46.15%
-0.160.0211.45%
Q2 2024
Q2Q % growth
-0.11 -0.10-0.01-7.84%
Q1 2024
Q2Q % growth
-0.12 -0.10-0.02-17.65%
Q3 2023
Q2Q % growth
-0.26 -0.08-0.18-218.63%
MIRA Yearly EPS VS EstimatesMIRA Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 -0.2 -0.4 -0.6
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS50% 50% 0% 0%
RevenueN/A N/A N/A N/A